Avelios Medical–SEVERAL: investment, 202502 financing round Series A €30m led by Sequoia Capital

	Period	2025-02-06
	Money taker	Avelios Medical GmbH
	Money source	SEVERAL
	Product	HIS 2.0 hospital information system (Avelios Medical)
	Product 2	venture capital
	Person	Biad, Anas (Sequoia Capital 202502 Partner)
	Person 2	Bach, Daniela (High-Tech Gründerfonds 202502 Principal)

High-Tech Gründerfonds Management GmbH. (2/6/25). "Press Release: Modular. Data-driven. Connected. Avelios Medical Secures €30 Million from Sequoia Capital for Its Next-generation Hospital Information System". Munich.

> The funding round is one of the largest Series A rounds in digital health in recent months.

> Avelios Medical offers the HIS of the future: designed around hospital workflows, powered by modular microservices, and based on structured data to enable AI-driven care.

> Leading hospitals are successfully using Avelios Medical’s software as the modern alternative in the HIS market.

Avelios Medical, provider of a modern hospital information system (HIS), has raised €30 million in Series A funding led by Sequoia Capital alongside existing investors Revent & HTGF. With this funding, Avelios accelerates its mission to become the leading operating system for intelligent patient care.

The funding from Sequoia Capital, an early backer of companies like Apple, Nvidia, Google, Airbnb, and WhatsApp, underscores Avelios Medical’s potential to drive digitization in healthcare. Entirely built from scratch, its hospital information system provides the launchpad for continuous innovation and the successful use of AI in medicine.

Great Potential

With SAP exiting the HIS market by 2030, hundreds of German and European hospitals must rethink their system landscape. This presents a once-in-a-generation opportunity to overhaul hospital IT, elevating the quality of care, and boosting process efficiency.

For example, preventable medication errors claim 65,000 lives each year in Germany alone – outpacing road traffic fatalities (Sources: BARMER, WHO). The cause: outdated IT systems, which too often do not make data available at the right time in the right format. For the same reason, according to a study by Marburger Bund, doctors spend more than three hours a day on administrative tasks.

A new operating system for intelligent patient care

Determined to fi x the root cause, Avelios’ three founders built an entire HIS from scratch – designed to empower doctors and nurses, not burden them. The result: an operating system for intelligent patient care designed to seamlessly align with treatment workfl ows, slashing documentation effort, and connecting data across sectors. By recording structured data along the entire patient journey, Avelios unlock’s AI’s full potential – enabling innovations like automated diagnostics.

Avelios Medical covers the full scope of a hospital information system – from treatment documentation to administrative processes to a patient portal. The platform relies on the highest data protection and security standards. All data is stored exclusively in highly secure data centers in Europe or directly in the customers’ local infrastructure. Thanks to a modular microservice architecture, hospitals can fl exibly adapt the system to their specific needs and choose between a step-by-step implementation or a single-step replacement.

“Building a complete hospital information system, including documentation, admin, billing, patient portal and more, is not for the faint-hearted, yet this is precisely what Avelios has built. We were astounded by the depth and breadth of the product, as well as the feedback from their customers, which count some of the largest public and private hospitals in Germany. We are thrilled to partner with these exceptional founders and team as they deliver the modern operating system our healthcare deserves.”
Anas Biad, Partner at Sequoia Capital

Leading hospitals already rely on Avelios

Avelios is already the core component of the digitization strategy of leading hospitals. Sana, one of Germany’s largest private hospital chains with 56 facilities, and renowned university hospitals such as the Hospital of the Ludwig-Maximilians-University Munich or the Hannover Medical School already rely on Avelios’ software and its integrated patient portal.

“Sequoia has consciously turned away from the classic, short-term investment cycle and focuses on companies that solve fundamental problems. The digitization of patient care requires long-term thinking and sustainable innovation. With Sequoia, we can deliver exactly that – a system built to stand the test of time.”
Christian Albrecht, co-founder of Avelios

Founding team of Avelios Medical (Picture: Avelios Medical)

About Avelios Medical

Avelios Medical is revolutionizing medical care with its state-of-the-art hospital information system (HIS). Avelios Medical’s HIS 2.0 puts the treatment process at the center of digitization and, based on structured data, optimizes hospital processes, reduces documentation effort, and intelligently connects patient data – from admission to billing.

The company was founded in 2020 by Christian Albrecht, Nicolas Jakob, and Dr. Sebastian Krammer. For more information, visit avelios.com.

Press Contact
Claire Dove
Email: [email protected]
Phone: +49 173 6772 819

About HTGF – High-Tech Gründerfonds

HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in the pre-seed and seed phase and can participate significantly in further financing rounds, since 2024 with the HTGF Opportunity growth fund. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more than 770 start-ups and successfully sold shares in more than 190 companies.

The Federal Ministry for Economic Affairs and Climate Action, KfW Capital and numerous companies are invested in the HTGF seed funds. Investors in the HTGF Opportunity growth fund include the ERP Special Fund and KfW with the resources of the Zukunftsfonds (“Future Fund”). Further information can be found at HTGF.de or on LinkedIn and on the Zukunftsfonds page.

Media contact
High-Tech Gründerfonds Management GmbH
Tobias Jacob, Senior Marketing & Communications Manager
T.: +49 228 – 82300 – 121
[email protected]

Daniela Bach – Principal / Authorized Signatory